Abbott Laboratories Total Liabilities 2010-2024 | ABT

Abbott Laboratories total liabilities for the quarter ending December 31, 2024 were $34.328B, a 0.2% decline year-over-year.

  • Abbott Laboratories total liabilities for 2023 were $34.387B, a 8.38% decline from 2022.
  • Abbott Laboratories total liabilities for 2022 were $37.533B, a 4.18% decline from 2021.
  • Abbott Laboratories total liabilities for 2021 were $39.172B, a 0.94% decline from 2020.

Abbott Laboratories Total Liabilities 2010-2024 | ABT

  • Abbott Laboratories total liabilities for 2023 were $34.387B, a 8.38% decline from 2022.
  • Abbott Laboratories total liabilities for 2022 were $37.533B, a 4.18% decline from 2021.
  • Abbott Laboratories total liabilities for 2021 were $39.172B, a 0.94% decline from 2020.
Related Stocks
Company NameMarket
Cap
Boston Scientific (BSX)$154.8B
Stryker (SYK)$151B
EssilorLuxottica (ESLOY)$128.8B
Medtronic (MDT)$116.5B
Lonza Group Ag (LZAGY)$48.7B
Haleon (HLN)$43B
Agilent Technologies (A)$42.1B
GE HealthCare Technologies (GEHC)$40.5B
ResMed (RMD)$34.8B
Terumo (TRUMY)$27.7B
Koninklijke Philips (PHG)$25.8B
Zimmer Biomet Holdings (ZBH)$20.4B
Insulet (PODD)$20.2B
Baxter (BAX)$15.7B
Smith & Nephew SNATS (SNN)$11B
Sunny Optical Technology (SNPTF)$10B
BellRing Brands (BRBR)$10B
Bio-Rad Laboratories (BIO)$9.7B
Demant (WILYY)$7.9B
Lantheus Holdings (LNTH)$6.3B
Prestige Consumer Healthcare (PBH)$4.3B
ICU Medical (ICUI)$3.9B
Envista Holdings (NVST)$3.7B
Perrigo (PRGO)$3.4B
Haemonetics (HAE)$3.2B
GN Store Nord (GNNDY)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
QuidelOrtho (QDEL)$2.8B
Neogen (NEOG)$2.3B
LeMaitre Vascular (LMAT)$2.2B